In consequence to the investment, Novo Holdings will gain a minority stake in MedGenome. Speaking on the investment from Novo Holdings, MeGenome in their statement have stated that, “Novo's investment will strengthen MedGenome's scale beyond India and South Asia into Africa and the Middle East and democratise access to genetic testing and personal healthcare across emerging markets” (Source: Live Mint). The Argus team consisted of Abhinav Bhalaik (Partner), Armaan Patkar (Partner), Mayank Jhunjhunwala (Senior Associate), Reha Mehta (Associate), Rohan Aneja (Associate), and Megh Panchal (Associate). Read more at: Live Mint, PR Newswire

---

September 1, 2022